A Missense Variant in TREML2 Reduces Risk of Alzheimer’s Disease in a Han Chinese Population

Molecular Neurobiology

Volumn 54, Issue 2, 2017, Pages 977-982

  Jiang, Teng ^a,b   Wan, Yu ^c   Zhou, Jun Shan ^a   Tan, Meng Shan ^c   Huang, Qing ^a   Zhu, Xi Chen ^d   Lu, Huan ^d   Wang, Hui Fu ^d   Chen, Qi ^d   Tan, Lin ^c   Zhang, Ying Dong ^a   Tan, Lan ^c,d   Yu, Jin Tai ^b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c QINGDAO UNIVERSITY   (China)

^d NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer s disease; Han Chinese; TREML2; Variant

Indexed keywords

APOLIPOPROTEIN E4; IMMUNOGLOBULIN RECEPTOR; TREML2 PROTEIN, HUMAN;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; BONFERRONI CORRECTION; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE; GENETIC SUSCEPTIBILITY; HAN CHINESE; HETEROZYGOTE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; RECESSIVE GENE; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS; TREML2 GENE; VALIDATION STUDY; ASIAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION; GENETIC VARIATION; GENETICS; HEALTH SURVEY; RISK FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; MALE; MUTATION, MISSENSE; POPULATION SURVEILLANCE; RECEPTORS, IMMUNOLOGIC; RISK FACTORS;

EID: 84955263698     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-016-9706-8     Document Type: Article

References (26)

1. Jiang T, Yu JT, Tan L (2012) Novel disease-modifying therapies for Alzheimer’s disease. J Alzheime Dis: JAD 31(3):475–492. doi:10.3233/JAD-2012-120640
2. Jiang T, Yu JT, Tian Y, Tan L (2013) Epidemiology and etiology of Alzheimer’s disease: from genetic to non-genetic factors. Curr Alzheim Res 10(8):852–867
3. Karch CM, Cruchaga C, Goate AM (2014) Alzheimer’s disease genetics: from the bench to the clinic. Neuron 83(1):11–26. doi:10.1016/j.neuron.2014.05.041
4. Yu JT, Tan L, Hardy J (2014) Apolipoprotein e in Alzheimer’s disease: an update. Annu Rev Neurosci 37:79–100. doi:10.1146/annurev-neuro-071013-014300
5. Tanzi RE (2012) The genetics of Alzheimer disease. Cold Spring Harbor Perspect Med 2(10):a006296. doi:10.1101/cshperspect.a006296
6. Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C, DeStafano AL, Bis JC et al (2013) Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease. Nat Genet 45(12):1452–1458. doi:10.1038/ng.2802
7. Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, Cruchaga C, Sassi C et al (2013) TREM2 variants in Alzheimer’s disease. N Engl J Med 368(2):117–127. doi:10.1056/NEJMoa1211851
8. Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, Snaedal J, Bjornsson S, Huttenlocher J et al (2013) Variant of TREM2 associated with the risk of Alzheimer’s disease. N Engl J Med 368(2):107–116. doi:10.1056/NEJMoa1211103
9. Benitez BA, Cooper B, Pastor P, Jin SC, Lorenzo E, Cervantes S, Cruchaga C (2013) TREM2 is associated with the risk of Alzheimer’s disease in Spanish population. Neurobiology of aging 34 (6):1711 e1715-1717. doi:10.1016/j.neurobiolaging.2012.12.018
10. Pottier C, Wallon D, Rousseau S, Rovelet-Lecrux A, Richard AC, Rollin-Sillaire A, Frebourg T, Campion D et al (2013) TREM2 R47H variant as a risk factor for early-onset Alzheimer’s disease. J Alzheim Dis: JAD 35(1):45–49. doi:10.3233/JAD-122311
11. Ruiz A, Dols-Icardo O, Bullido MJ, Pastor P, Rodriguez-Rodriguez E, Lopez De Munain A, De Pancorbo MM, Perez-Tur J et al (2014) Assessing the role of the TREM2 p.R47H variant as a risk factor for Alzheimer’s disease and frontotemporal dementia. Neurobiol Aging 35(2):444 e441–444. doi:10.1016/j.neurobiolaging.2013.08.011
12. Gonzalez Murcia JD, Schmutz C, Munger C, Perkes A, Gustin A, Peterson M, Ebbert MT, Norton MC et al (2013) Assessment of TREM2 rs75932628 association with Alzheimer’s disease in a population-based sample: the Cache County Study. Neurobiol Aging 34(12):2889 e2811–2883. doi:10.1016/j.neurobiolaging.2013.06.004
13. Hooli BV, Parrado AR, Mullin K, Yip WK, Liu T, Roehr JT, Qiao D, Jessen F et al (2014) The rare TREM2 R47H variant exerts only a modest effect on Alzheimer disease risk. Neurology 83(15):1353–1358. doi:10.1212/WNL.0000000000000855
14. Cuyvers E, Bettens K, Philtjens S, Van Langenhove T, Gijselinck I, van der Zee J, Engelborghs S, Vandenbulcke M et al (2014) Investigating the role of rare heterozygous TREM2 variants in Alzheimer’s disease and frontotemporal dementia. Neurobiol Aging 35(3):726 e711–729. doi:10.1016/j.neurobiolaging.2013.09.009
15. Yu JT, Jiang T, Wang YL, Wang HF, Zhang W, Hu N, Tan L, Sun L et al (2014) Triggering receptor expressed on myeloid cells 2 variant is rare in late-onset Alzheimer’s disease in Han Chinese individuals. Neurobiol Aging 35(4):937 e931–933. doi:10.1016/j.neurobiolaging.2013.10.075
16. Benitez BA, Jin SC, Guerreiro R, Graham R, Lord J, Harold D, Sims R, Lambert JC et al (2014) Missense variant in TREML2 protects against Alzheimer’s disease. Neurobiol Aging 35(6):1510
17. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s disease. Neurology 34(7):939–944
18. Yu JT, Miao D, Cui WZ, Ou JR, Tian Y, Wu ZC, Zhang W, Tan L (2012) Common variants in toll-like receptor 4 confer susceptibility to Alzheimer’s disease in a Han Chinese population. Curr Alzheim Res 9(4):458–466
19. Jiang T, Yu JT, Tan MS, Wang HF, Wang YL, Zhu XC, Zhang W, Tan L (2014) Genetic variation in PICALM and Alzheimer’s disease risk in Han Chinese. Neurobiol Aging 35(4):934 e931–933. doi:10.1016/j.neurobiolaging.2013.09.014
20. Cruchaga C, Kauwe JS, Harari O, Jin SC, Cai Y, Karch CM, Benitez BA, Jeng AT et al (2013) GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer’s disease. Neuron 78(2):256–268. doi:10.1016/j.neuron.2013.02.026
21. Ford JW, McVicar DW (2009) TREM and TREM-like receptors in inflammation and disease. Curr Opin Immunol 21(1):38–46. doi:10.1016/j.coi.2009.01.009
22. Wijsman EM, Pankratz ND, Choi Y, Rothstein JH, Faber KM, Cheng R, Lee JH, Bird TD et al (2011) Genome-wide association of familial late-onset Alzheimer’s disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOE. PLoS Genet 7(2), e1001308. doi:10.1371/journal.pgen.1001308
23. Zhang X, Yu JT, Li J, Wang C, Tan L, Liu B, Jiang T (2015) Bridging integrator 1 (BIN1) genotype effects on working memory, hippocampal volume, and functional connectivity in young healthy individuals. Neuropsychopharmacol Off Publ Am College Neuropsychopharmacol 40(7):1794–1803. doi:10.1038/npp.2015.30
24. Yu JT, Tan L (2012) The role of clusterin in Alzheimer’s disease: pathways, pathogenesis, and therapy. Mol Neurobiol 45(2):314–326. doi:10.1007/s12035-012-8237-1
25. Lu RC, Wang H, Tan MS, Yu JT, Tan L (2014) TMEM106B and APOE polymorphisms interact to confer risk for late-onset Alzheimer’s disease in Han Chinese. J Neural Transm 121(3):283–287. doi:10.1007/s00702-013-1106-x
26. Wang HF, Yu JT, Zhang W, Wang W, Liu QY, Ma XY, Ding HM, Tan L (2012) SORCS1 and APOE polymorphisms interact to confer risk for late-onset Alzheimer’s disease in a Northern Han Chinese population. Brain Res 1448:111–116. doi:10.1016/j.brainres.2012.01.067